STM Journals Peer-reviewed research from Consortium e-Learning Network

International Journal of Oncological Nursing and Practices Original Research

Assessing the Increasing Incidence of Prostate Cancer in Urban Delhi: Risk Factors, Early Detection, and Treatment Challenges

  1. Eric Kwasi Elliason Faculty of Allied Health Sciences, Desh Bhagat University
  2. Atul Khajuria Faculty of Allied Health Sciences, Desh Bhagat University
  3. Stephen Monday Faculty of Allied Health Sciences, Desh Bhagat University
  4. J. Samuel Kamanda Faculty of Allied Health Sciences, Desh Bhagat University

Abstract

Background: Prostate cancer has emerged as the second most prevalent cancer among men in India, with rapidly increasing incidence rates in urban areas like Delhi. This rise is attributed to urbanization, lifestyle changes (high-fat diets, tobacco use, sedentary behavior), increased life expectancy, and improved diagnostics. Despite its growing burden, low awareness, limited screening programs, and treatment barriers hinder early detection and effective management. This study examines the epidemiological trends, risk factors, and systemic challenges in prostate cancer care in Delhi to inform targeted public health interventions.

Objective: To assess the increasing incidence of prostate cancer in urban Delhi by analyzing risk factors, evaluating early detection practices, and identifying treatment barriers to guide policy and interventions.

Methods: A cross-sectional study was conducted with 500 prostate cancer patients (purposively sampled) and 500 age-matched controls (stratified random sampling). Data were collected via questionnaires, interviews, and medical records, and analyzed using SPSS (descriptive statistics, chi-square tests, logistic regression) and NVivo (thematic analysis).

Results: (1) Risk Factors: High tobacco use (60% smokeless, 50% smoking), sedentary lifestyles (70%), and high-fat diets (50%) were prevalent among patients. (2) Awareness: Only 30% of patients and 10% of controls knew about PSA testing; symptom awareness (e.g., difficulty urinating) was higher in patients (90%) than in controls (36%). (3) Screening: Post-campaign screening participation rose from 12 to 40%, though financial constraints (50–60%) and cultural stigma (30%) persisted. (4) Treatment Challenges: Cost (50% patients, 60% controls) and limited healthcare access hindered timely care.

Conclusion: The study highlights the urgent need for multifaceted interventions, targeted awareness campaigns, subsidized screening, lifestyle modifications, and stigma reduction to address the rising prostate cancer burden in Delhi. Policy efforts must prioritize equitable access to early detection and treatment to improve outcomes.

Keywords

References (10)

  1. Bhargavi R, Khilwani B, Kour B, Shukla N, Aradhya R, Sharma D, et al. Prostate cancer in India: Current perspectives and the way forward. J Reprod Healthc Med. 2023; 4: 8.
  2. Sankarapillai J, Krishnan S, Ramamoorthy T, Sudarshan KL, Mathur P. Descriptive epidemiology of prostate cancer in India, 2012–2019: Insights from the National Cancer Registry Programme. Indian Journal of Urology. 2024;40(3):167-173. doi:10.4103/iju.iju_27_24
  3. Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, Law SC, Ahn YO, Xiang YB, Yeole BB, Shin HR, Shanta V, Woo ZH, Martin N, Sumitsawan Y, Sriplung H, Barboza AO, Eser S, Nene BM, Suwanrungruang K, Jayalekshmi P, Dikshit R, Wabinga H, Esteban DB, Laudico A, Bhurgri Y, Bah E, Al-Hamdan N. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol. 2010 Feb; 11(2): 165–73. doi:10.1016/S1470–2045(09)70335–3. Epub 2009 Dec 10. PMID: 20005175.
  4. Talamini R, Franceschi S, Lavecchia C, Guarneri S, Negri E. Smoking Habits and Prostate Cancer: A Case-Control Study in Northern Italy. Preventive Medicine. 1993;22(3):400-408. doi:10.1006/pmed.1993.1033
  5. Al-Fayez S, El-Metwally A. Cigarette smoking and prostate cancer: A systematic review and meta-analysis of prospective cohort studies. Tobacco Induced Diseases. 2023;21(February):1-12. doi:10.18332/tid/157231
  6. Hariharan K, Padmanabha V. Demography and disease characteristics of prostate cancer in India. Indian J Urol. 2016 Apr–Jun; 32(2): 103–8. doi:10.4103/0970–1591.174774. PMID: 27127351; PMCID: PMC4831497.
  7. Adithya G Rao, Winniecia Dkhar, Sharath S, Rajagopal Kadavigere, Abhimanyu Pradhan. Knowledge, Awareness and Practice towards Screening for Prostate Cancer: A Systematic Review and Meta-Analysis. Ethiopian Journal of Health Sciences. 2023;33(3). doi:10.4314/ejhs.v33i3.19
  8. Prinja S, Dixit J, Gupta N, Dhankhar A, Kataki AC, Roy PS, et al. Financial toxicity of cancer treatment in India: towards closing the cancer care gap. Frontiers in Public Health. 2023;11. doi:10.3389/fpubh.2023.1065737
  9. Vapiwala N, Miller D, Laventure B, Woodhouse K, Kelly S, Avelis J, et al. Stigma, beliefs and perceptions regarding prostate cancer among Black and Latino men and women. BMC Public Health. 2021;21(1). doi:10.1186/s12889-021-10793-x
  10. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: A Cancer Journal for Clinicians. 2020;70(1):7-30. doi:10.3322/caac.21590